Skip to content

Clinical trials

Observational Hemorrhage trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Phase: Observational Country / region: United Kingdom Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20111
20121
20131
20142
20151
20191
20203
20212
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer2
Anthos Therapeutics, Inc.1
AstraZeneca1
Cardiovascular Center Frankfurt1
European Society of Anaesthesiology1
Fondazione Angelo Bianchi Bonomi1
GlaxoSmithKline1
Imperial College London1
King's College Hospital NHS Trust1
Liverpool University Hospitals NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage16
Stroke5
Atrial Fibrillation4
Cardiovascular Diseases2
Coronary Disease2
Myocardial Infarction2
Thrombosis2
Wounds and Injuries2
Acute Coronary Syndrome1
Angina, Stable1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.